Literature DB >> 3973979

Inhibitory effect of interferon on the genetic and oncogenic transformation by viral and cellular genes.

M Perucho, M Esteban.   

Abstract

The rodent established cell lines LTk- and NIH 3T3 have been used as recipients in gene transfer experiments to study the effect of interferon treatment on the genetic and oncogenic transformation by several genes of viral and cellular origin. Our results show that interferon severely inhibits, to a similar extent, the stable transformation of Ltk- and NIH 3T3 cells by the chicken thymidine kinase (tk) gene, Ecogpt gene, simian virus 40, v-Ha-ras, and human c-Ha-ras and c-Ki-ras oncogenes. These results are consistent with an inhibition by interferon at the level of stabilization or integration, or both, of exogenous DNA sequences in the recipient cells, with an apparent effect on gene expression.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3973979      PMCID: PMC254782     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

Review 1.  Antitumor effects of interferon.

Authors:  I Gresser; M G Tovey
Journal:  Biochim Biophys Acta       Date:  1978-10-27

Review 2.  Biochemistry of interferons and their actions.

Authors:  P Lengyel
Journal:  Annu Rev Biochem       Date:  1982       Impact factor: 23.643

3.  Genetic and physical linkage of exogenous sequences in transformed cells.

Authors:  M Perucho; D Hanahan; M Wigler
Journal:  Cell       Date:  1980-11       Impact factor: 41.582

4.  T24 human bladder carcinoma oncogene is an activated form of the normal human homologue of BALB- and Harvey-MSV transforming genes.

Authors:  E Santos; S R Tronick; S A Aaronson; S Pulciani; M Barbacid
Journal:  Nature       Date:  1982-07-22       Impact factor: 49.962

5.  Transforming genes of human bladder and lung carcinoma cell lines are homologous to the ras genes of Harvey and Kirsten sarcoma viruses.

Authors:  C J Der; T G Krontiris; G M Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

6.  Transforming DNA integrates into the host chromosome.

Authors:  D M Robins; S Ripley; A S Henderson; R Axel
Journal:  Cell       Date:  1981-01       Impact factor: 41.582

7.  Normal rat cell lines deficient in nuclear thymidine kinase.

Authors:  W C Topp
Journal:  Virology       Date:  1981-08       Impact factor: 3.616

8.  Expression of a bacterial gene in mammalian cells.

Authors:  R C Mulligan; P Berg
Journal:  Science       Date:  1980-09-19       Impact factor: 47.728

9.  Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene.

Authors:  L F Parada; C J Tabin; C Shih; R A Weinberg
Journal:  Nature       Date:  1982-06-10       Impact factor: 49.962

10.  Homologous recombination in mammalian cells mediates formation of a functional gene from two overlapping gene fragments.

Authors:  B R de Saint Vincent; G M Wahl
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

View more
  9 in total

Review 1.  Cytokine-induced tumor suppressors: a GRIM story.

Authors:  Dhan V Kalvakolanu; Shreeram C Nallar; Sudhakar Kalakonda
Journal:  Cytokine       Date:  2010-04-10       Impact factor: 3.861

2.  Virus attenuation and identification of structural proteins of vaccinia virus that are selectively modified during virus persistence.

Authors:  E Paez; S Dallo; M Esteban
Journal:  J Virol       Date:  1987-08       Impact factor: 5.103

3.  Murine gamma interferon inhibits v-mos-induced fibroblast transformation via down regulation of retroviral gene expression.

Authors:  B Seliger; G Kruppa; K Pfizenmaier
Journal:  J Virol       Date:  1987-08       Impact factor: 5.103

4.  Regulated expression of nuclear genes by T3 RNA polymerase and lac repressor, using recombinant vaccinia virus vectors.

Authors:  D Rodriguez; Y W Zhou; J R Rodriguez; R K Durbin; V Jimenez; W T McAllister; M Esteban
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

5.  Tumor suppressive protein gene associated with retinoid-interferon-induced mortality (GRIM)-19 inhibits src-induced oncogenic transformation at multiple levels.

Authors:  Sudhakar Kalakonda; Shreeram C Nallar; Ping Gong; Daniel J Lindner; Simeon E Goldblum; Sekhar P Reddy; Dhananjaya V Kalvakolanu
Journal:  Am J Pathol       Date:  2007-09-06       Impact factor: 4.307

6.  Interferon prevents the generation of spontaneous deletions at the left terminus of vaccinia virus DNA.

Authors:  E Paez; M Esteban
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

7.  GRIM-19: A Double-edged Sword that Regulates Anti-Tumor and Innate Immune Responses.

Authors:  Shreeram C Nallar; Sudhakar Kalakonda; Peng Sun; Dhan V Kalvakolanu
Journal:  Transl Oncogenomics       Date:  2008-03-17

8.  Genetic Programs Driving Oncogenic Transformation: Lessons from in Vitro Models.

Authors:  Eros Di Giorgio; Harikrishnareddy Paluvai; Raffaella Picco; Claudio Brancolini
Journal:  Int J Mol Sci       Date:  2019-12-12       Impact factor: 5.923

9.  Depression of early phase of HTLV-I infection in vitro mediated by human beta-interferon.

Authors:  C D'Onofrio; C F Perno; P Mazzetti; G Graziani; R Calio'; E Bonmassar
Journal:  Br J Cancer       Date:  1988-05       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.